Category Archives: Global News Feed

SYDNEY, June 21, 2022 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (OTC: PARNF), a fully integrated, commercial-stage pharmaceutical company focused on developing, manufacturing and marketing innovative animal health solutions, provides notice of its Annual General Meeting to be held Friday, 15th July 2022 at 8:30 a.m. (Australian Eastern Standard Time).

Read more:
Parnell Pharmaceuticals Gives Notice of Annual General Meeting and Explanatory Memorandum

COPENHAGEN, Denmark and BOSTON, June 21, 2022 (GLOBE NEWSWIRE) -- BioPorto A/S (CPH:BIOPOR) (BioPorto) today provided details of a previously announced session with members of its management team.

More here:
Moderated Webcast with BioPorto’s Management

First-of-a-kind Isotope Production System continues to progress towards commercial, industrial-scale production of medical isotopes for cancer therapeutics

Excerpt from:
ITM: New Isotope Production System at Bruce Power Successfully Produces First Medical Isotope

New York, NY, and Tel Aviv, ISRAEL, June 21, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that it has retained Moneta Advisory Partners (“Moneta”) to act as strategic advisors for the Company’s planned listing on a national exchange and the crowdfunding for the Company’s COVID and Long COVID theragnostics-focused joint venture 3CL Pharma. 3CL Pharma is the developer of the Phase 2/3-stage dual mechanism (3CL protease inhibitor and anti-cytokine) therapeutics candidate Tollovir™ for the treatment of hospitalized COVID-19 patients and the distributor of Tollovid®, the proprietary 3CL protease inhibitor immune support dietary supplement currently available on Amazon and www.MyTollovid.com.

Continue reading here:
Todos Medical Retains Moneta Advisory Partners as Strategic Advisors for National Exchange Listing and 3CL Pharma Spinoff

Webcast presentation tomorrow, Wednesday, 22 June 2022, at 14.00 CET / 8 AM ET, www.glpg.com

Read more here:
Galapagos to acquire CellPoint and AboundBio to accelerate access to next-generation cell therapies

Ad hoc announcement pursuant to Art. 53 LR

Here is the original post:
Novartis plans to petition the U.S. Court of Appeals for the Federal Circuit for further review to uphold validity of the Gilenya® (fingolimod)...

- Vote to approve share consolidation adjourned to July 6, 2022

Read more from the original source:
Aeterna Zentaris Announces Results of Annual Meeting of Shareholders

WESTMINSTER, Colo., June 21, 2022 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO) today announced that Jacob Ma-Weaver has joined its Board of Directors.

Link:
Jacob Ma-Weaver Joins ARCA biopharma Board of Directors

TORONTO, June 21, 2022 (GLOBE NEWSWIRE) -- Spectral Medical Inc. ("Spectral" or the "Company") (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, as well as commercializing a new proprietary platform targeting the renal replacement therapy market through its wholly-owned subsidiary Dialco Medical Inc. ("Dialco"), today announced the results of its Annual and Special Meeting of shareholders (the "Shareholders") held on June 20, 2022 (the "Meeting"). The Company is pleased to announce that all resolutions put forward in the Management Information Circular dated May 6, 2022 (the "Circular") to its Shareholders were approved.

See the original post:
Spectral Medical Inc. Announces Results of Annual and Special Meeting of Shareholders

-- Phase 2b Study in MAB Pulmonary Infections Ongoing and Enrolling as Planned

Read the original:
Paratek Pharmaceuticals’ NUZYRA® Receives FDA Fast Track Designation for the Treatment of Pulmonary Nontuberculous Mycobacterial (NTM) Disease...